Jung M - Search Results

1

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.

Wagner JM, Hackanson B, Lübbert M, Jung M. Wagner JM, et al. Among authors: jung m. Clin Epigenetics. 2010 Dec;1(3-4):117-136. doi: 10.1007/s13148-010-0012-4. Epub 2010 Nov 9. Clin Epigenetics. 2010. PMID: 21258646 Free PMC article.

2

Pyridylalanine-containing hydroxamic acids as selective HDAC6 inhibitors.

Schäfer S, Saunders L, Schlimme S, Valkov V, Wagner JM, Kratz F, Sippl W, Verdin E, Jung M. Schäfer S, et al. Among authors: jung m. ChemMedChem. 2009 Feb;4(2):283-90. doi: 10.1002/cmdc.200800196. ChemMedChem. 2009. PMID: 19090524

3

Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).

Huber K, Schemies J, Uciechowska U, Wagner JM, Rumpf T, Lewrick F, Süss R, Sippl W, Jung M, Bracher F. Huber K, et al. Among authors: jung m. J Med Chem. 2010 Feb 11;53(3):1383-6. doi: 10.1021/jm901055u. J Med Chem. 2010. PMID: 20030343

4

[New approach to determine the pharmacodynamic effects of histone deacetylases inhibitors].

Wagner JM, Jung M. Wagner JM, et al. Among authors: jung m. Pharm Unserer Zeit. 2010 May;39(3):173-4. doi: 10.1002/pauz.201090027. Pharm Unserer Zeit. 2010. PMID: 20425766 German. No abstract available.

5

[Valproic acid as a histone deacetylase inhibitor. New application for a well-known drug].

Wagner JM, Bug G, Jung M. Wagner JM, et al. Among authors: jung m. Pharm Unserer Zeit. 2010 May;39(3):197-203. doi: 10.1002/pauz.201000366. Pharm Unserer Zeit. 2010. PMID: 20425769 Review. German. No abstract available.

6

[Bookmarks in the book of life. Epigenetics].

Wagner JM, Jung M. Wagner JM, et al. Among authors: jung m. Pharm Unserer Zeit. 2010 May;39(3):176-82. doi: 10.1002/pauz.201000363. Pharm Unserer Zeit. 2010. PMID: 20425771 Review. German. No abstract available.

7

Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.

Furdas SD, Shekfeh S, Bissinger EM, Wagner JM, Schlimme S, Valkov V, Hendzel M, Jung M, Sippl W. Furdas SD, et al. Among authors: jung m. Bioorg Med Chem. 2011 Jun 15;19(12):3678-89. doi: 10.1016/j.bmc.2011.01.063. Epub 2011 Feb 2. Bioorg Med Chem. 2011. PMID: 21353783

8

A bioluminogenic HDAC activity assay: validation and screening.

Halley F, Reinshagen J, Ellinger B, Wolf M, Niles AL, Evans NJ, Kirkland TA, Wagner JM, Jung M, Gribbon P, Gul S. Halley F, et al. Among authors: jung m. J Biomol Screen. 2011 Dec;16(10):1227-35. doi: 10.1177/1087057111416004. Epub 2011 Aug 10. J Biomol Screen. 2011. PMID: 21832257

9

A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2.

Kaufmann KB, Gründer A, Hadlich T, Wehrle J, Gothwal M, Bogeska R, Seeger TS, Kayser S, Pham KB, Jutzi JS, Ganzenmüller L, Steinemann D, Schlegelberger B, Wagner JM, Jung M, Will B, Steidl U, Aumann K, Werner M, Günther T, Schüle R, Rambaldi A, Pahl HL. Kaufmann KB, et al. Among authors: jung m. J Exp Med. 2012 Jan 16;209(1):35-50. doi: 10.1084/jem.20110540. Epub 2012 Jan 9. J Exp Med. 2012. PMID: 22231305 Free PMC article.

10

HDAC6 as a target for antileukemic drugs in acute myeloid leukemia.

Hackanson B, Rimmele L, Benkißer M, Abdelkarim M, Fliegauf M, Jung M, Lübbert M. Hackanson B, et al. Among authors: jung m. Leuk Res. 2012 Aug;36(8):1055-62. doi: 10.1016/j.leukres.2012.02.026. Epub 2012 Mar 29. Leuk Res. 2012. PMID: 22464548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,366 results

Search Page